P347: Vedolizumab for primary sclerosing cholangitis associated with inflammatory bowel disease: A multicentre cohort study from the GETAIDECCO '18 Vienna
2018
P348: 3D reconstructions in complex fistulising perianal Crohn’s disease to aid decision-makingECCO '18 Vienna
2018
P349: Deep enteroscopy with a through-the-scope ballon catheter system in paediatric patients with IBDECCO '18 Vienna
2018
P350: Conventional biomarkers in newly diagnosed Crohn’s disease patients may predict early disease progressionECCO '18 Vienna
2018
P351: Bowel ultrasound is accurate in assessing disease activity in ulcerative colitisECCO '18 Vienna
2018
P352: Is diagnostic delay associated with the risk of colectomy in patients with ulcerative colitis? Results of a study of the Austrian IBD study groupECCO '18 Vienna
2018
P353: Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea: An updateECCO '18 Vienna
2018
P354: Refinement and confirmation of psychometric properties of the Inflammatory Bowel Disease Distress Scale (IBD-DS): A new tool to measure disease-specific distressECCO '18 Vienna
2018
P355: Prevalence, clinical characteristics and outcomes of CMV colitis in a cohort of 95 patients with ulcerative colitis: A 7-year retrospective analysisECCO '18 Vienna
2018
P356: The role of endoscopic activity in the coagulation profile of clinical remission Crohn’s diseaseECCO '18 Vienna
2018
P357: Healthcare and medication utilisation in Singapore adult inflammatory bowel disease patients receiving immunomodulators and biologicsECCO '18 Vienna
2018
P358: Factors associated with disability in inflammatory bowel disease (IBD): A cross-sectional study in outpatientsECCO '18 Vienna
2018
P360: TrueColours ulcerative colitis (TCUC): Will patients with UC complete digital questionnaires in real-time?ECCO '18 Vienna
2018
P361: Patterns of use and durability of initial and sequential biological agents in a large Paediatric inflammatory bowel disease observational cohortECCO '18 Vienna
2018
P362: Six-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patientsECCO '18 Vienna
2018
P363: Discontinuation of 5-aminosalicylates after starting biologic therapy in patients with ulcerative colitis is not associated with adverse outcomesECCO '18 Vienna
2018